No Benefit to Combo Tx to Prevent Recurrent C diff in IBD No Benefit to Combo Tx to Prevent Recurrent C diff in IBD
Given the high efficacy of fecal microbiota transplantation, adding bezlotoxumab may not provide further reduction in recurrence.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology Source Type: news
More News: Gastroenterology | Transplants